(Q64336691)

English

An Open-label Safety and Tolerability Study of Nusinersen (ISIS 396443) in Participants With Spinal Muscular Atrophy (SMA) Who Previously Participated in ISIS 396443-CS2 (NCT01703988) or ISIS 396443-CS10 (NCT01780246)

clinical trial

In more languages

edit

Statements

instance of

clinical trial

0 references

title

An Open-label Study to Assess the Safety and Tolerability of ISIS 396443 in Patients With Spinal Muscular Atrophy Who Previously Participated in 396443-CS2 or 396443-CS10 (English)

0 references

0 references

0 references

United States of America

0 references

start time

January 2014

0 references

end time

January 2017

0 references

number of participants

47

0 references

clinical trial phase

phase I clinical trial

0 references

research site

Columbia University Irving Medical Center

0 references

study type

interventional study

0 references

Identifiers

ClinicalTrials.gov ID

NCT02052791

0 references

(Q64336691)

An Open-label Safety and Tolerability Study of Nusinersen (ISIS 396443) in Participants With Spinal Muscular Atrophy (SMA) Who Previously Participated in ISIS 396443-CS2 (NCT01703988) or ISIS 396443-CS10 (NCT01780246)

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)